Latest Insider Transactions at Bio Age Labs, Inc. (BIOA)
This section provides a real-time view of insider transactions for Bio Age Labs, Inc. (BIOA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BioAge Labs, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BioAge Labs, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 09
2025
|
Paul D Rubin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
18,000
-100.0%
|
$216,000
$12.0 P/Share
|
|
Dec 09
2025
|
Paul D Rubin Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
18,000
+50.0%
|
$108,000
$6.57 P/Share
|
|
Dec 04
2025
|
Paul D Rubin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
68,897
-100.0%
|
$688,970
$10.19 P/Share
|
|
Dec 04
2025
|
Paul D Rubin Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
68,897
+50.0%
|
$275,588
$4.11 P/Share
|
|
Oct 03
2024
|
Vijay Satyanand Pande |
BUY
Open market or private purchase
|
Indirect |
25,306
+2.21%
|
$480,814
$19.9 P/Share
|
|
Oct 02
2024
|
Vijay Satyanand Pande |
BUY
Open market or private purchase
|
Indirect |
67,096
+5.78%
|
$1,274,824
$19.73 P/Share
|
|
Oct 01
2024
|
Vijay Satyanand Pande |
BUY
Open market or private purchase
|
Indirect |
126,793
+10.99%
|
$2,409,067
$19.73 P/Share
|
|
Sep 27
2024
|
Shane Barton Principal Accounting Officer |
BUY
Open market or private purchase
|
Direct |
2,632
+50.0%
|
$47,376
$18.0 P/Share
|
|
Sep 27
2024
|
Cormorant Asset Management, LP |
BUY
Open market or private purchase
|
Indirect |
450,000
+21.64%
|
$8,100,000
$18.0 P/Share
|
|
Sep 27
2024
|
Cormorant Asset Management, LP |
BUY
Conversion of derivative security
|
Indirect |
1,179,529
+50.0%
|
-
|
|
Sep 27
2024
|
Patrick G Enright |
BUY
Open market or private purchase
|
Indirect |
400,000
+18.95%
|
$7,200,000
$18.0 P/Share
|
|
Sep 27
2024
|
Patrick G Enright |
BUY
Conversion of derivative security
|
Indirect |
1,310,589
+50.0%
|
-
|
|
Sep 27
2024
|
Vijay Satyanand Pande |
BUY
Open market or private purchase
|
Indirect |
900,000
+50.0%
|
$16,200,000
$18.0 P/Share
|
|
Sep 27
2024
|
Vijay Satyanand Pande |
BUY
Conversion of derivative security
|
Indirect |
2,113,975
+43.64%
|
-
|
|
Sep 27
2024
|
James Healy |
BUY
Open market or private purchase
|
Indirect |
666,665
+44.18%
|
$11,999,970
$18.0 P/Share
|
|
Sep 27
2024
|
James Healy |
BUY
Conversion of derivative security
|
Indirect |
1,638,236
+50.0%
|
-
|